In vitro susceptibility studies of plasmodium falciparum isolates and clones against type II antifolate drugs

Chemotherapy

Volumn 42, Issue 5, 1996, Pages 318-323

  Anga, Hooi Hoon ^a   Lam, Chan Kit ^a   Wahh, Mak Joon ^b  

^a SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

^b INSTITUTE FOR MEDICAL RESEARCH   (Malaysia)

Author keywords

Clones; Cycloguanil; Isolates; Plasmodium falciparum; Pyrimethamine

Indexed keywords

CYCLOGUANIL; FOLIC ACID ANTAGONIST; PYRIMETHAMINE;

ARTICLE; CELL CLONE; CONTROLLED STUDY; DRUG SENSITIVITY; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL;

EID: 0029792504     PISSN: 00093157     EISSN: 14219794     Source Type: Journal    
DOI: 10.1159/000239461     Document Type: Article

References (36)

1. Rumans LW, Dennis DT, Atmo-soedjono S: Fansidar’ resistant falciparum malaria in Indonesia. Lancet 1979;ii:580-581.
2. Center for Disease Control: Plasmodium falciparum malaria contracted in Thailand resistant to chloroquine and sulfonamide-pyri-mcthamine-Illinois. Morbid Mortality Weekly Rep 1980;29:493-495.
3. Hurwitz ES, Johnson D, Campbell CC: Resistance of Plasmodium falciparum malaria to sulfadoxine-pyri-methaminc (Fansidar®) in a refugee camp in Thailand. Lancet 1981;i: 1068-1070.
4. Watt G, Shanks GD: Pyrimctham-ine/sulfadoxine for falciparum malaria. Lancet 1991;338:700-701.
5. Spencer HC, Watkins WM, Six-smith DG, Koech DK, Chulay JD: A new in-vitro test for pyrimeth-amine-sulfadoxine susceptibility of Plasmodium falciparum and its correlation with in-vivo resistance in Kenya. Bull WHO 1984;62:615-621.
6. Killimali VAEB, Mkufya AR: In vivo assessment of the sensitivity of Plasmodium falciparum to sulfa-doxine-pyrimcthaminc combination (Fansidar’) in six loxalities in Tanzania where chloroquine-resis-tant P. falciparum has been detected. Trans R Soc Trop Med 1985; 79:482-483.
7. Gubler J: Sulfadoxine/pyrimetham-ine resistant malaria from West or Central Africa. Br Med J 1988;296: 433.
8. Lege-Oguntoye L, Adagu SI, Wer-blinska B, Ogala WN, Slotboom AB: Resistance of Plasmodium falciparum to sulfadoxine/pyrimethamine combination in semi-immune children in Zaire, Northern Nigeria. Trans R Soc Trop Med Hyg 1990; 84:505-506.
9. Salako LA, Adio RA, Sowunmi A, Walker O: Parenteral sulphacoxine-pyrimethamine (Fansidar®): An effective and safe but under-used method of anti-malarial treatment. Trans R Soc Trop Med Hyg 1991; 84:641-643.
10. Schapira A, Bygbjerg C, Jopsen S, Flachs H, Weis BH: The susceptibility of Plasmodium falciparum to sul-fadoxine and pyrimethamine: Correlation of in vivo and in vitro results. Am J Trop Med Hyg 1986;35: 239-245.
11. Hellgren U, Kihamia CM, Bergqvist Y, Lebbad M, Premji Z, Rombo L: Standard and reduced doses of sul-fadoxine-pyrimcthamine for treatment of Plasmodium falciparum in Tanzania, with determination of drug concentrations and susceptibility in vitro. Trans R Soc Trop Med Hyg 1990;84:469-473.
12. Timmermans PM, Hess U, Jones ME: Pyrimethamine/sulfadoxinc resistant falciparum malaria in East Africa. Lancet 1982;i: 1181.
13. Wernsdorfer WH. Konznetsov RL: Drug-resistant malaria - Occurrence, control and surveillance. Bui WHO 1980;58:341-352.
14. Bruce-Chwatt LJ: Chemoprophylaxis of malaria in Africa: ‘the spent magic bullet'. Br Med J 1982,285: 674-676.
15. Peters W: Antimalarial drug resistance: An increasing world problem. Br Med Bull 1982;38:187-192.
16. Olsen W: Why not proguanil in malaria chemoprophylaxis? Lancet 1983;i:649.
17. McLarty DG, Webber RH, Jaatinen M: Chemoprophylaxis of malaria in non-immune residents in Dar es Salaam. Tanzania. Lancet 1984;ii:656-658.
18. Schmidt LH, Loo TL, Fradkin R, Hughes HB: Antimalarial activities of triazine metabolites of chlorguan-ide and dichlorguanide. Proc Soc Exp Biol Med 1952;80:367-370.
19. Crowthcr AF, Levi AA: Proguanil: Isolation of metabolite with high antimalarial activity. Br J Pharmacol Chcmother 1953:8:93.
20. Ang HH, Chan KL, Mak JW: Clones of West African Plasmodium falciparum obtained by limiting dilution, their characterization with regard to glucose phosphate isomerase (EC 5.3.1.9) (abstract). 17th Malaysian Microbiology Symposium Penang, 1994, p 46.
21. Ang HH, Chan KL, Mak JW: Isoenzyme typing of some clones of Plasmodium falciparum from Malaysia (abstract 3 PI). 31st Annual Scientific Seminar, Malaysian Society of Parasitology and Tropical Medicine, Kuala Lumpur, 1995, p 13.
22. Ang HH, Chan KL, Mak JW: Variations in GPI (EC 5.3.1.9), LDH (EC 1.1.1.27) and ADA (EC 3.5.4.4) in isolate and clones of Plasmodium falciparum from Thailand, (abstract CIII-12). Malaysian Science and Technology Congress, Kuala Lumpur, 1995.
23. Ang HH, Chan KL, Mak JW: Quantitative assessment of antimalarial activity from Malaysian Plasmodium falciparum isolates by the modified in vitro microtechnique. An-timicrob Agents Chemother 1995; 39:626-628.
24. Träger W, Jensen JB: Human malaria parasites in continuous culture. Science 1976;193:673-675.
25. Träger W, Jensen JB: Cultivation of erythrocyte stages. Bull WHO 1977; 5:363-365.
26. Rosario V: Cloning of naturally occurring mixed infections of malaria parasites. Science 1981;212:1037-1038.
27. Richards WHG, Maples BK: Studies on Plasmodium falciparum in continuous cultivation 1. The effect of chloroquine and pyrimethamine on parasite growth and viability. Ann Trop Med Parasitol 1979;73: 99-107.
28. Schefler WC: Statistics for Health Professionals. London, Addison-Wesley, 1984. pp 251-254.
29. Träger W, Terhakovec M, Lyand-vert L, Stanley H, Lanners N, Gu-bcrt E: Clones of malaria parasite Plasmodium falciparum obtained by microscopic selection; their characterization with regards to knobs, chloroquine sensitivity and formation of gamctocytes. Proc Natl Acad Sei USA 1981;78:6527-6530.
30. Thaithong S: Clones of different sensitivities in drug-resistant isolates of Plasmodium falciparum. Bull WHO 1983;61:702-712.
31. Thaithong S, Beale GH, Fenton B, McBride J, Rosario V, Walker A, Wallikcr D: Clonal diversity in a single isolate of the malaria parasite Plasmodium falciparum. Trans R Soc Trop Med Hyg 1984;78:242-245.
32. Graves PM, Carter R, Keystone JS; Seeley DC Jr: Drug sensitivity and isoenzyme type in cloned lines of Plasmodium falciparum. Am J Trop Med Hyg 1984;33:212-219.
33. Webster HK, Thaithong S, Pava-nand K, Yongvanitchit K, Piswandi C, Boudreau EF: Cloning and characterization of mefloquine-resistant Plasmodium falciparum from Thailand. Am J Trop Med Hyg 1985;34: 1022-1027.
34. Thaithong S, Beale GH, Chutmong-kul M: Variability in drug susceptibility amongst clones and isolates of Plasmodium falciparum. Trans R Soc Trop Med Hyg 1988;82:33-36.
35. Oduola AM, Weatherly NF, Bowdre JH, Desjardins RE: Plasmodium falciparum cloning by single erythrocyte micromanipulation and heterogeneity in vitro. Exp Parasitol 1988; 66:86-95.
36. World Health Organization: Instructions for use of the microtest kit for the assessment of the response of Plasmodium falciparum to chloroquine and mefloquine in vitro (MAP/82). Geneva, Switzerland.